Hologic Inc (HOLX)

42.29
NASDAQ : Health Care
Prev Close 42.23
Day Low/High 42.12 / 42.55
52 Wk Low/High 32.64 / 42.97
Avg Volume 2.20M
Exchange NASDAQ
Shares Outstanding 279.30M
Market Cap 11.79B
EPS 1.20
P/E Ratio 36.09
Div & Yield N.A. (N.A)

Latest News

Cramer: Top 10 Bull Markets Right Now

Cramer: Top 10 Bull Markets Right Now

Bull market number one, perhaps of all time: the financials.

Medtronic Earnings Rebound in Third Quarter, Shares Climb

Medtronic Earnings Rebound in Third Quarter, Shares Climb

The company discusses potential share repurchases and its acquisition strategy.

Deals of the Week: Valentine Couplings and Breakups

Deals of the Week: Valentine Couplings and Breakups

SoftBank's $3.3 billion deal for Fortress topped the notable transactions this week.

Hologic Moves Up In Analyst Rankings, Passing Marsh & McLennan Companies

Hologic Moves Up In Analyst Rankings, Passing Marsh & McLennan Companies

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Hologic, Inc. has taken over the #121 spot from Marsh & McLennan Companies Inc.

FDA Grants PMA Approval For Hologic's Aptima® Hepatitis C Quant Dx Assay

FDA Grants PMA Approval For Hologic's Aptima® Hepatitis C Quant Dx Assay

HCV viral load test now available alongside HIV-1 assay and women's health menu on the fully automated Panther system

Wall Street Smashes Records for Fourth Day in a Row After Rocky Session

Wall Street Smashes Records for Fourth Day in a Row After Rocky Session

Wall Street smashes records again on Tuesday, closing at all-time highs for its fourth consecutive session.

Stocks Find Upward Momentum Again as Chances of a Rate Hike Rise

Stocks Find Upward Momentum Again as Chances of a Rate Hike Rise

Wall Street hold small gains on Tuesday after Federal Reserve Chair Janet Yellen plays the part of both dove and hawk.

Stocks Mixed as Fed's Yellen Talks Rates on Capitol Hill

Stocks Mixed as Fed's Yellen Talks Rates on Capitol Hill

Wall Street is mixed on Tuesday morning after Federal Reserve Chair Janet Yellen champions the strength of the U.S. economy.

Hologic To Acquire Cynosure, Leader In Medical Aesthetics Systems And Technologies, In All-Cash Tender Offer That Combines Two Complementary Businesses

Hologic To Acquire Cynosure, Leader In Medical Aesthetics Systems And Technologies, In All-Cash Tender Offer That Combines Two Complementary Businesses

-Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate -

The S&P 500 Companies With the Most Diverse Boards

The S&P 500 Companies With the Most Diverse Boards

The most ethnically and gender diverse boards may surprise you.

Hologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System For The Treatment Of Abnormal Uterine Bleeding

Hologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System For The Treatment Of Abnormal Uterine Bleeding

--Smaller 6 mm Diameter and Product Updates Are Designed to Enhance Patient Comfort and Improve Physician Ease-of-Use--

Hologic Completes Divestiture Of Blood Screening Business

Hologic Completes Divestiture Of Blood Screening Business

- Strengthens Efforts to Build a Sustainable Growth Company -

Analysts' Actions -- Agco, AthenaHealth, Oshkosh, Hologic and More

Analysts' Actions -- Agco, AthenaHealth, Oshkosh, Hologic and More

Here are Wednesday's top research calls, including upgrades for Agco, AthenaHealth and Hologic, and a downgrade for Oshkosh.

FDA Grants PMA Approval For Hologic's Aptima® HIV-1 Quant Assay

FDA Grants PMA Approval For Hologic's Aptima® HIV-1 Quant Assay

--High-performing HIV viral load test now available alongside broad women's health menu on the fully automated Panther® system--

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

Hologic and Grifols have worked together since 1998 building a blood screening business, and now Hologic will sell its share to Grifols.

Hologic To Showcase Award-Winning Breast Screening And Interventional Solutions At RSNA 2016

Hologic To Showcase Award-Winning Breast Screening And Interventional Solutions At RSNA 2016

--New products spotlight Hologic's leading tomosynthesis technology, including the world's first dedicated prone biopsy system with 2D or 3D™ imaging--

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Here's a window into what institutional investors may be doing and how to profit from that.